TB and MDR-TB infographic: We’re leaving no-one behind
Treatment for multi-drug resistant TB (MDR-TB) is long, arduous and financially crippling for many patients in low-income countries
Abstract
Treatment for multi-drug resistant TB (MDR-TB) is long, arduous and financially crippling for many patients in low-income countries. Find out how our research is helping improve mental wellbeing and treamtment completion rates for some of the most vulnerable and marginalised populations in Nepal, Bangladesh and China.
This research is supported by the Department for International Development’s COMDIS–HSD Programme which is led by the University of Leeds
Citation
COMDIS. TB and MDR-TB infographic: We’re leaving no-one behind. COMDIS-HSD Tools, Tips and Guides, (2017)
Links
Updates to this page
Published 1 January 2017